ClinicalTrials.gov record
Completed Phase 3 Interventional

Recombinant Factor VIIa in Acute Intracerebral Haemorrhage

ClinicalTrials.gov ID: NCT00127283

Public ClinicalTrials.gov record NCT00127283. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 11, 2026, 9:26 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomised, Double-Blind, Placebo Controlled, Multi-Centre, Parallel Groups Confirmatory Efficacy and Safety Trial of Activated Recombinant Factor VII (NovoSeven®/Niastase®) in Acute Intracerebral Haemorrhage

Study identification

NCT ID
NCT00127283
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
829 participants

Conditions and interventions

Interventions

  • eptacog alfa (activated) Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2005
Primary completion
Dec 31, 2006
Completion
Dec 31, 2006
Last update posted
Jan 11, 2017

2005 – 2007

United States locations

U.S. sites
77
U.S. states
35
U.S. cities
68
Facility City State ZIP Site status
Novo Nordisk Investigational Site Birmingham Alabama 35209
Novo Nordisk Investigational Site Mobile Alabama 36617
Novo Nordisk Investigational Site Phoenix Arizona 85013
Novo Nordisk Investigational Site Fort Smith Arkansas 72901
Novo Nordisk Investigational Site Los Angeles California 90024
Novo Nordisk Investigational Site Oceanside California 92056
Novo Nordisk Investigational Site Orange California 92868-4280
Novo Nordisk Investigational Site Sacramento California 95816
Novo Nordisk Investigational Site San Diego California 92103
Novo Nordisk Investigational Site San Francisco California 94110-3594
Novo Nordisk Investigational Site San Francisco California 94143-0780
Novo Nordisk Investigational Site Stanford California 94305
Novo Nordisk Investigational Site Denver Colorado 80204
Novo Nordisk Investigational Site Denver Colorado 80262
Novo Nordisk Investigational Site Englewood Colorado 80113
Novo Nordisk Investigational Site Hartford Connecticut 06102
Novo Nordisk Investigational Site Washington D.C. District of Columbia 20010
Novo Nordisk Investigational Site Jacksonville Florida 32209
Novo Nordisk Investigational Site Melbourne Florida 32901
Novo Nordisk Investigational Site Tallahassee Florida 32308
Novo Nordisk Investigational Site Tampa Florida 33606
Novo Nordisk Investigational Site Atlanta Georgia 30320
Novo Nordisk Investigational Site Augusta Georgia 30912-3260
Novo Nordisk Investigational Site Decatur Georgia 33033
Novo Nordisk Investigational Site Honolulu Hawaii 96813
Novo Nordisk Investigational Site Chicago Illinois 60611
Novo Nordisk Investigational Site Chicago Illinois 60612
Novo Nordisk Investigational Site Maywood Illinois 60153
Novo Nordisk Investigational Site Peoria Illinois 61637
Novo Nordisk Investigational Site Fort Wayne Indiana 46805
Novo Nordisk Investigational Site Indianapolis Indiana 46260
Novo Nordisk Investigational Site Iowa City Iowa 52242
Novo Nordisk Investigational Site Lexington Kentucky 40536
Novo Nordisk Investigational Site Louisville Kentucky 40202
Novo Nordisk Investigational Site Baltimore Maryland 21287
Novo Nordisk Investigational Site Boston Massachusetts 02118
Novo Nordisk Investigational Site Boston Massachusetts 02144
Novo Nordisk Investigational Site Boston Massachusetts 02215
Novo Nordisk Investigational Site Detroit Michigan 48201
Novo Nordisk Investigational Site Golden Valley Minnesota 55422
Novo Nordisk Investigational Site Blackwater Mississippi 39216
Novo Nordisk Investigational Site Kansas City Missouri 64111
Novo Nordisk Investigational Site St Louis Missouri 63110-1010
Novo Nordisk Investigational Site St Louis Missouri 63110
Novo Nordisk Investigational Site Las Vegas Nevada 89109
Novo Nordisk Investigational Site Lebanon New Hampshire 03756-0001
Novo Nordisk Investigational Site Cherry Hill New Jersey 08034
Novo Nordisk Investigational Site Hackensack New Jersey 07465
Novo Nordisk Investigational Site Ridgewood New Jersey 07450
Novo Nordisk Investigational Site Buffalo New York 14215
Novo Nordisk Investigational Site New York New York 10032
Novo Nordisk Investigational Site Stony Brook New York 11794-8121
Novo Nordisk Investigational Site Chapel Hill North Carolina 27599-7025
Novo Nordisk Investigational Site Charlotte North Carolina 28232-2861
Novo Nordisk Investigational Site Durham North Carolina 27705
Novo Nordisk Investigational Site Winston-Salem North Carolina 27103
Novo Nordisk Investigational Site Cincinnati Ohio 45267
Novo Nordisk Investigational Site Cleveland Ohio 44195
Novo Nordisk Investigational Site Portland Oregon 97225
Novo Nordisk Investigational Site Portland Oregon 97239
Novo Nordisk Investigational Site Allentown Pennsylvania 18103-6208
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19104
Novo Nordisk Investigational Site Philadelphia Pennsylvania 19107
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15212-4746
Novo Nordisk Investigational Site Pittsburgh Pennsylvania 15213-2546
Novo Nordisk Investigational Site Charleston South Carolina 29425
Novo Nordisk Investigational Site Chattanooga Tennessee 37403
Novo Nordisk Investigational Site Hashville Tennessee 37232
Novo Nordisk Investigational Site Memphis Tennessee 38163
Novo Nordisk Investigational Site Nashville Tennessee 37205
Novo Nordisk Investigational Site Dallas Texas 75390-8897
Novo Nordisk Investigational Site Houston Texas 77030
Novo Nordisk Investigational Site San Antonio Texas 78229
Novo Nordisk Investigational Site Burlington Vermont 05401
Novo Nordisk Investigational Site Charlottesville Virginia 22908
Novo Nordisk Investigational Site Seattle Washington 98102
Novo Nordisk Investigational Site Madison Wisconsin 53792-3236

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 90 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00127283, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 11, 2017 · Synced May 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00127283 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →